Evidence map›Paper›PMID 27112571›Full record

ArticleNucleic acids research2016

HMGN proteins modulate chromatin regulatory sites and gene expression during activation of naïve B cells.

Shaofei Zhang, Iris Zhu, Tao Deng, Takashi Furusawa, Mark Rochman, Melanie S Vacchio, Remy Bosselut, Arito Yamane, Rafael Casellas, David Landsman and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Unraveling linker histone interactions in nucleosomes.Current opinion in structural biology · 2021
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Shaofei ZhangProtein Section, Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Iris ZhuComputational Biology Branch, National Center for Biotechnology Information, National Library of Medicine, Bethesda, MD 20892, USA.
Tao DengProtein Section, Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Takashi FurusawaProtein Section, Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Mark RochmanProtein Section, Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Melanie S VacchioLaboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Remy BosselutLaboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Arito YamaneGenomics and Immunity, NIAMS, National Institutes of Health, Bethesda, MD 20892, USA.
Rafael CasellasGenomics and Immunity, NIAMS, National Institutes of Health, Bethesda, MD 20892, USA.
David LandsmanComputational Biology Branch, National Center for Biotechnology Information, National Library of Medicine, Bethesda, MD 20892, USA landsman@ncbi.nlm.nih.gov.
Michael BustinProtein Section, Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA bustin@helix.nih.gov.
National Cancer Institute · USCenter for Cancer Research · USNational Center for Biotechnology Information · USNational Institutes of Health · USNational Institute of Arthritis and Musculoskeletal and Skin Diseases · US

Funding

RAG and AID biologyZIAAR041148 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI O'SHEA, JOHN · 2009 to 2025
$44.8M
Genetic Analysis of T-cell DifferentiationZIABC010671 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI BOSSELUT, REMY · 2009 to 2025
$34.3M
Gene Regulatory Sequences And Protein Binding in Genome SequencesZIALM000084 · NLM · NATIONAL LIBRARY OF MEDICINE · PI LANDSMAN, DAVID · 2009 to 2025
$7.7M
6 · The paper itself

Abstract

The activation of naïve B lymphocyte involves rapid and major changes in chromatin organization and gene expression; however, the complete repertoire of nuclear factors affecting these genomic changes is not known. We report that HMGN proteins, which bind to nucleosomes and affect chromatin structure and function, co-localize with, and maintain the intensity of DNase I hypersensitive sites genome wide, in resting but not in activated B cells. Transcription analyses of resting and activated B cells from wild-type and Hmgn(-/-) mice, show that loss of HMGNs dampens the magnitude of the transcriptional response and alters the pattern of gene expression during the course of B-cell activation; defense response genes are most affected at the onset of activation. Our study provides insights into the biological function of the ubiquitous HMGN chromatin binding proteins and into epigenetic processes that affect the fidelity of the transcriptional response during the activation of B cell lymphocytes.

Indexed as

Gene Expression RegulationAnimalsB-LymphocytesChromatinDeoxyribonuclease IEpigenesis, GeneticHMGN1 ProteinHMGN2 ProteinHMGN ProteinsLymphocyte ActivationMaleMiceNucleosomesPromoter Regions, GeneticProtein BindingRegulatory Sequences, Nucleic AcidChromatinDeoxyribonuclease IHMGN1 ProteinHMGN2 ProteinHMGN ProteinsNucleosomes

Identifiers

PMID27112571
PMCPMC5009722
OpenAlexW2342966089

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.